BioArctic AB (STU:B9A) Other Current Liabilities : €11.21 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is BioArctic AB Other Current Liabilities?

BioArctic AB's other current liabilities for the quarter that ended in Mar. 2024 was €11.21 Mil.

BioArctic AB's quarterly other current liabilities declined from Sep. 2023 (€9.34 Mil) to Dec. 2023 (€5.23 Mil) but then increased from Dec. 2023 (€5.23 Mil) to Mar. 2024 (€11.21 Mil).

BioArctic AB's annual other current liabilities declined from Dec. 2021 (€7.92 Mil) to Dec. 2022 (€3.69 Mil) but then increased from Dec. 2022 (€3.69 Mil) to Dec. 2023 (€5.23 Mil).

BioArctic AB Other Current Liabilities Historical Data

The historical data trend for BioArctic AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Other Current Liabilities Chart

BioArctic AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

BioArctic AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

BioArctic AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

BioArctic AB Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of BioArctic AB's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

BioArctic AB (STU:B9A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (STU:B9A) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

BRCTF:USA BIOA B:Sweden 0RV2:UK B9A:Germany

Address

Warfvinges vag 35, Stockholm, SWE, SE-112 51

Website

https://www.bioarctic.se

BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB (STU:B9A) Headlines

No Headlines